Singapore markets close in 1 hour 13 minutes

SAB Biotherapeutics, Inc. (SABSW)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.0379+0.0079 (+26.33%)
At close: 12:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3N/A
S&P500 52-week change 322.38%
52-week high 30.0379
52-week low 30.0300
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 85.93M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,187.90%

Management effectiveness

Return on assets (ttm)-35.29%
Return on equity (ttm)-95.51%

Income statement

Revenue (ttm)2.24M
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)-85.90%
Gross profit (ttm)N/A
EBITDA -34.42M
Net income avi to common (ttm)-42.19M
Diluted EPS (ttm)0.2920
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)56.57M
Total cash per share (mrq)6.13
Total debt (mrq)5.91M
Total debt/equity (mrq)10.31%
Current ratio (mrq)5.45
Book value per share (mrq)6.21

Cash flow statement

Operating cash flow (ttm)-25.12M
Levered free cash flow (ttm)-17.95M